No no no...you guys didn't think that...You all said the FDA nod wasn't necessary for this Harvard trial...that the Review board was good enough. I argued that couldn't and shouldn't be the case...
Anyway, good to see leadership get it right with FDA inclusion all the way!
News 
Market Data 
Discover 
